HK1080080A1 - C-取代的三環異噁唑啉衍生物及其作為抗抑鬱劑的用途 - Google Patents

C-取代的三環異噁唑啉衍生物及其作為抗抑鬱劑的用途

Info

Publication number
HK1080080A1
HK1080080A1 HK06100165.3A HK06100165A HK1080080A1 HK 1080080 A1 HK1080080 A1 HK 1080080A1 HK 06100165 A HK06100165 A HK 06100165A HK 1080080 A1 HK1080080 A1 HK 1080080A1
Authority
HK
Hong Kong
Prior art keywords
depressants
substituted tricyclic
isoxazoline derivatives
tricyclic isoxazoline
derivatives
Prior art date
Application number
HK06100165.3A
Other languages
English (en)
Inventor
José Ignacio Andrés-Gil
José Manuel Bartolomé-Nebreda
Rosa Maria Alvarez-Escobar
Margaretha Henrica Maria Bakker
Antonius Adrianus Hendrikus Petrus Megens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1080080A1 publication Critical patent/HK1080080A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK06100165.3A 2002-08-12 2006-01-04 C-取代的三環異噁唑啉衍生物及其作為抗抑鬱劑的用途 HK1080080A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02078322 2002-08-12
PCT/EP2003/050374 WO2004016621A1 (en) 2002-08-12 2003-08-12 C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants

Publications (1)

Publication Number Publication Date
HK1080080A1 true HK1080080A1 (zh) 2006-04-21

Family

ID=31725449

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06100165.3A HK1080080A1 (zh) 2002-08-12 2006-01-04 C-取代的三環異噁唑啉衍生物及其作為抗抑鬱劑的用途

Country Status (15)

Country Link
US (1) US7465741B2 (zh)
EP (1) EP1537124B1 (zh)
JP (1) JP4681295B2 (zh)
CN (1) CN1329396C (zh)
AR (1) AR040967A1 (zh)
AT (1) ATE368669T1 (zh)
AU (1) AU2003262571B2 (zh)
CA (1) CA2494235C (zh)
DE (1) DE60315311T2 (zh)
DK (1) DK1537124T3 (zh)
ES (1) ES2290537T3 (zh)
HK (1) HK1080080A1 (zh)
PT (1) PT1537124E (zh)
TW (1) TW200409777A (zh)
WO (1) WO2004016621A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1492796B1 (en) * 2002-04-02 2007-09-05 Janssen Pharmaceutica N.V. Substituted amino isoxazoline derivatives and their use as anti-depressants.
ES2331144T3 (es) 2004-11-26 2009-12-22 Janssen Pharmaceutica Nv Derivados de isoxazolina-indol con actividad antipsicotica y ansiolitica mejorada.
CN102786515B (zh) * 2012-04-13 2014-07-23 湖南大学 2-（2,2-二甲基-2,3-二氢苯并呋喃-5-基）吗啉及其制备方法与应用
CN112374984A (zh) * 2020-11-06 2021-02-19 苏州求索生物科技有限公司 一种2-溴-4-羟基苯甲醚的制备工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0361577B1 (en) * 1988-09-19 1993-05-05 Akzo N.V. Tetrahydronaphthalene and indane derivatives
GB9318691D0 (en) * 1993-09-09 1993-10-27 Merck Sharp & Dohme Therapeutic agents
AU681695B2 (en) 1993-09-15 1997-09-04 Merck Sharp & Dohme Limited Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
ATE246682T1 (de) * 1993-12-24 2003-08-15 Daiichi Suntory Pharma Co Ltd Benzothiazinderivate
JP3161737B2 (ja) 1996-01-05 2001-04-25 ヘキスト・マリオン・ルセル・インコーポレイテツド ＣＮＳ活性を有する４，５―ジヒドロナフト［１，２―ｃ］イソキサゾールおよびその誘導体
US6187774B1 (en) 1996-03-04 2001-02-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and pharmaceutical applications thereof
WO1997047601A1 (fr) * 1996-06-11 1997-12-18 Yoshitomi Pharmaceutical Industries, Ltd. Composes heterocycliques fusionnes et leurs utilisations medicinales
JP2003521443A (ja) * 1998-06-19 2003-07-15 ハー・ルンドベック・アクチエゼルスカベット ４，５，６及び７−インドール及びインドリン誘導体、その製造方法及びその使用方法
JP3953424B2 (ja) * 2001-02-21 2007-08-08 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 抗うつ薬としてのイソキサゾリン誘導体
EP1492796B1 (en) * 2002-04-02 2007-09-05 Janssen Pharmaceutica N.V. Substituted amino isoxazoline derivatives and their use as anti-depressants.
WO2004018482A2 (en) * 2002-08-21 2004-03-04 Janssen Pharmaceutica N.V. C6- and c9-substituted chromeno[4, 3-c]isoxazoline derivatives and their use as anti-depressants

Also Published As

Publication number Publication date
JP4681295B2 (ja) 2011-05-11
TW200409777A (en) 2004-06-16
ATE368669T1 (de) 2007-08-15
AU2003262571B2 (en) 2009-02-12
DK1537124T3 (da) 2007-10-29
DE60315311T2 (de) 2008-04-17
ES2290537T3 (es) 2008-02-16
EP1537124B1 (en) 2007-08-01
US7465741B2 (en) 2008-12-16
CN1675222A (zh) 2005-09-28
EP1537124A1 (en) 2005-06-08
AR040967A1 (es) 2005-04-27
US20050256119A1 (en) 2005-11-17
CA2494235C (en) 2011-10-11
CN1329396C (zh) 2007-08-01
JP2005537304A (ja) 2005-12-08
AU2003262571A1 (en) 2004-03-03
DE60315311D1 (de) 2007-09-13
PT1537124E (pt) 2007-10-16
WO2004016621A1 (en) 2004-02-26
CA2494235A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
GB0315111D0 (en) Substituted 5-membered ring compounds and their use
IL174512A0 (en) Pyrazolo and imidazo-pyrimidine derivatives
AU2003236135A1 (en) Aralkyl-alcohol peiperazine derivatives and their uses as antidepressant
ZA200604725B (en) Benzoxazine derivatives and uses thereof
HK1081954A1 (en) Novel 1,4-diazabicycloalkane derivatives, their preparation and use
EG25683A (en) Benzoxazine derivatives and uses thereof
IL163868A0 (en) Hermiasterlin derivatives and uses thereof
PL377770A1 (pl) Podstawione benzoksazynony i ich zastosowanie
GB0220214D0 (en) Compounds and their use
HK1080072A1 (zh) 經取代的氨基異噁唑啉衍生物及其作為抗抑鬱藥的用途
HK1080080A1 (zh) C-取代的三環異噁唑啉衍生物及其作為抗抑鬱劑的用途
GB0316910D0 (en) Fluorocombretastatin and derivatives thereof
GB0227906D0 (en) Compounds and their use
GB0300805D0 (en) Compounds and their use
GB0300804D0 (en) Compounds and their use
GB0301143D0 (en) Compounds and their use
GB0307231D0 (en) 7-Nitroindoline derivatives and their uses
GB0230134D0 (en) Compounds and their use
GB0218031D0 (en) Compounds and their use
GB0230281D0 (en) Compounds and their use
GB0220215D0 (en) Compounds and their use
HK1087114A1 (en) Substituted benzoxazinones and uses thereof
SI1562918T1 (sl) Substituirani benzoksazinoni in uporaba le-teh
HU0203951D0 (en) Magic ring
GB0230135D0 (en) Compounds and their uses